Ticagrelor Without Concomitant Aspirin No Better Than Standard DAPT in PCI
Ticagrelor without aspirin offered no additional benefits compared with conventional dual antiplatelet therapy in patients undergoing PCI for either CAD or ACS.
Dual Antiplatelet Therapy (DAPT)
Genotype-Guided Antiplatelet Therapy Feasible, Effective
Genotype-guided therapy improved outcomes in patients who were CYP2C19 intermediate and poor metabolizers.
Benefits of Changing Dual Antiplatelet Therapy After Acute Coronary Syndrome
Switching DAPT after acute coronary syndrome provides benefits regardless of initial platelet reactivity.
ESC and EACTS Provide New Dual Antiplatelet Therapy Guidelines in Coronary Heart Disease
The European Society of Cardiology and European Association for Cardio-Thoracic Surgery have released a focused update on dual antiplatelet therapy use in coronary heart disease.
Dual Antiplatelet Therapy vs Aspirin Alone Post-CABG in Diabetes
No significant differences were observed between dual antiplatelet therapy and aspirin alone following coronary artery bypass grafting in patients with diabetes.
Revisiting Necessity of Full Dose Triple Therapy With DAPT for Routine PCI
All-cause death plus hospitalization possibly from bleeding were reduced in both rivaroxaban groups compared with the reference group.
Long-Term DAPT Reduced MACE After Complex PCI
Long-term dual antiplatelet therapy was associated with reduced MACE in patients who underwent complex percutaneous coronary intervention.
Prolonged DAPT Reduces Risk of Ischemic Events in Peripheral Arterial Disease
Prolonged DAPT correlated with a reduced risk of a composite of death, myocardial infarction, or cerebrovascular accidents in patients with peripheral arterial disease.
DAPT Duration After PCI: Similar Outcomes for Women and Men
After multivariate adjustment for baseline imbalances, researchers found no significant differences for the primary efficacy end point between genders.
DAPT Use Variable After PCI With Atrial Fibrillation
Within 30 days of PCI, 12.3% of patients switched from DAPT to monotherapy and 15% of patients received no antiplatelet therapy after PCI.
- Loading...
Loading...
Next post in Arrhythmia
Loading... 
Loading...